Form D · Pharmaceuticals
Alto Labs LLC
Los Angeles, CA · CIK 0002089151
Offering snapshot reported Oct 2, 2025 · SEC filing
- Reported sold
- $300K Offering amount: $400K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- Aug 14, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 2, 2025 | Initial | $300,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-559549
SAFE
Source: Form D, filed Oct 2, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Oliver Cohen | Executive |
| Matthew Makabeh | Executive |
| Adam Solomon | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1801 S Hill Street #200,
Los Angeles, CA, 90007
Phone: 310-709-1427
Los Angeles, CA, 90007
Phone: 310-709-1427